Automated insulin system for LADA diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests a hybrid closed-loop insulin pump system for people with LADA (a slow-progressing form of autoimmune diabetes). It aims to see if the system can improve blood sugar control and reduce hypoglycemia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with LADA (latent autoimmune diabetes in adults), meaning you were diagnosed after age 18, have positive islet antibodies, and did not need insulin right away.
- You are comfortable using an insulin pump and a continuous glucose monitor (CGM) and can learn to operate them.
- Your recent HbA1c (average blood sugar) is above 7.0%, or above 6.0% with low blood sugar episodes.
- You are willing to participate and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medicine called cofrogliptin can help protect the cells that make insulin in people with LADA, a type of diabetes that often needs insulin treatment. It may help keep your own insulin production going longer.
This trial tests a hybrid closed-loop system (an advanced insulin pump that automatically adjusts insulin) for people with diabetes who have had a kidney transplant. It may help improve blood sugar control and reduce the burden of managing diabetes after transplant.
This trial tests a hybrid closed-loop system that automatically adjusts insulin delivery. It may help you manage your blood sugar more easily if you currently give yourself daily insulin shots.
This trial tests a 'closed-loop' system that automatically adjusts insulin delivery for people with type 2 diabetes. If you already use insulin and certain diabetes medications, this study could help see if a smart insulin pump improves blood sugar control.
This study tests an artificial intelligence feature that helps the insulin pump deliver extra insulin before meals. It aims to improve blood sugar control for adults with type 1 diabetes who already use an automated insulin delivery system.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
Hear when a new Latent Autoimmune Diabetes in Adults (LADA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.